Drug List P1 Year

Unofficial (P1) Year Drug List

Cardiac / Hypertension Drugs

ACEI (Angiotensin Converting Enzyme Inhibitor)

benazepril Lotensin®
captopril Capoten®
enalapril Vasotec, Vaseretic®
fosinopril Monopril®
lisinopril Zestril®, Prinivil®
quinapril Accupril®
ramipril Altace®

Angiotensin II ReceptorAntagonist

irbesartan Avapro®
losartan Cozaar®
valsartan Diovan®

Beta-blocker (edited by s.fey)

Pharmacology
Inhibit β1-receptors in SinoAtrial / AtrialVentricular node
Decrease renin release
Increase vasodilation
Efficacy
Effective in lowering BP
No proven reduction in Cardiovascular (CV) mortality
Side Effects
Minor:
confusion, lethargy, impotence, nightmares
small increases in Triglyceride levels
small decrease in HDL levels
Major:
Bradycardia, bronchiospasms, vasospasm
Decreased tolerance to exercise
Variations in blood glucose can mask hypoglycemia
May aggravate CHF
Drugs, Doses, Half-Life, Brand Names (®)
Atenolol25 – 100 mg PO QD; T1/2 = 3 – 4 hours
Brand(s): Tenormin®
Metoprolol 50 -100 mg PO QD; T1/2 = 3 – 7 hours
Brand(s): Toprol®, Lopressor®
Propranolol 40 – 320 mg POQD; T1/2 = 3 – 5 hours
Brand(s): Inderal®
Labetalol100 – 200 PO BID; T1/2 = 6 – 8 hours
Brand(s): Normodyne®, Levatol®, Trandate®
Carvedilol6.25 – 25 mg PO QD, BID; T1/2 = 7 – 10 hours
Brand(s): Coreg

Calcium Channel Blocker

amlodipine Norvasc®

diltiazem Cardizem®
nifedipine Procardia XL®, Adalat CC®
verapamil Calan, Calan SR®

Calcium ChannelBlocker/ACEI

amlodipine/benazepril Lotrel®

Cardiac Glycoside

digoxin Lanoxin®

Diuretics

LoopDiuretics

bumetanide Bumex®
furosemideLasix®
torsemideDemadex®

Potassium Sparing Diuretics

spironolactone Aldactone®

Potassium Sparing/Thiazide Diuretics

triamterene/HCTZ Dyazide®

Thiazide Diuretics

chlorthalidone Hygroton®
hydrochlorothiazide Hydrodiuril®

α1 AdrenergicBlocking Agent

doxazosin Cardura®
terazosin Hytrin®
clonidine Catapres®

Vasodilating Agents

nitroglycerin (all forms) Nitroquick®, Nitrolingual®

Miscellaneous

H2 Antagonists

nizatidine Axid®

famotidine Pepcid®
cimetidine Tagamet®
ranitidine Zantac®

Proton Pump inhibitors

Lansoprazole Prevacid®
Pantoprazole Protonix®
Esomeprazole Nexium®
Omeprazole Prilosec®

Antitussives, Expectorants, and Mucolytic Agents

Dextromethorphan Benylin®
Guaifenesin Robitussin®

Sympathomimetic Agents

Pseudoephedrine Sudafed®

Analgesic/Antipyretic

aspirin
acetaminophenTylenol®, Excedrin®
ibuprofenMotrin®, Advil®, Nuprin®, Provel®
naproxen

Pain Relievers

hydrocodone Lortab®,Lorcet®,Vicodin®
fentanyl Duragesic®
acetaminophen withcodeineTylenol® with codeine

Dyslipidemia

HMG CoA Reductase Inhibitors:

Atorvastatin Lipitor®
Simvastatin Zocor®
Pravastatin Pravachol®
Rosuvastatin Crestor®
Lovastatin Mevacor®
Fluvastatin Lescol®

Miscellaneous:

Ezetimibe Zetia®

Bile Acid Sequestrants:

Cholestyramine Questran®
Colestipol Colestid®
Colesevelam WelChol™

Nicotinic Acid Derivatives:

Extended-release nicotinic acid Niaspan®
Sustained-release nicotinic acid
Crystalline nicotinic acid

Fibric Acid Derivatives:

Gemfibrozil Lopid®
Fenofibrate Tricor®

Combination Products:

Ezetimibe / simvastatin Vytorin®
Lovastatin / Niacin Advicor®

Diabetes Drugs

Classification Brand Name Generic Names

Sulfonylurea Diabeta/Micronase Glyburide
Glucotrol Glipizide
Meglitinides Prandin Repaglinide
Starlix Nateglinide
Biguanides Glucophage Metformin
Thiazolidinediones Avandia Rosiglitazone
Alpha-glucosidase Inhibitor
Acarbose Precose
Insulins Novolog
Insulin aspart
Insulin Humalog lispro
R Regular insulin Novolin R/Humulin
N NPH insulin isophane Novolin N/Humulin
Insulin glargine Lantus

Mechanisms of Action

Sulfonlyureas – stimulate insulin release from pancreatic beta-cells
Meglitinides – stimulate insulin release from pancreatic beta-cells
Biguanides – decreases glucose output from the liver & increases peripheral muscleglucose uptake
Thiazolidinediones (TZD) – decrease peripheral (skeletal muscle and adipose tissue)insulin resistance & decreases hepatic glucose production
Alpha-glucosidase Inhibitors – decreases the breakdown of carbohydrates in the brushborder of the small intestine
Insulin – recombinant DNA insulin that replaces endogenously produced insulin

AntibioticsCommunity related drugs

Diflucan®
Valtrex®
Omnicef®
Amoxil®
Augmentin
Zithromax®
Biaxin®
Cefzil®
Levaquin®
Tequin®
Avelox®
Cipro®
Tamiflu®
Macrobid
Doxycycline
Tetracycline
Minocin®
Flagyl®
Penicillin
Bactrim®

Asthma Drug List

Prescription Rescueβ-agonists

Albuterol (Proventil HFA/Ventolin)
Pirbuterol (Maxair Autohaler)

Anticholinergics

Ipratropium:
Ipratropium & Albuterol Combivent
Ipratropium Atrovent

Systemic Corticosteroids

Methylprednisolone (DosePak only)
Prednisone Tablets

Long Term Controllers

β-agonists
Salmeterol Serevent Inhaler

Inhaled Corticosteroids

Budesonide Rhinocort
Beclomethasone
Beclomethasone MDI and nasal Vancenase, Vancenase AQ/Beconase,
Vanceril/Beclovent)
Beclomethasone diproprionate HFA Qvar
FluticasoneSalmeterol Advair
Fluticasone Flonase
Fluticasone Flovent
Mometasone Furoate Monohydrate Nasonex
Triamcinolone Azmacort

Leukotriene Modifiers

Montelukast Singulair
Zafirlukast Accolate

Mast Cell Stabilizers

Cromolyn Intal

Inhaled Anticholinergics

Tiotropium Spiriva

Miscellaneous

Theophylline (various types and names)

Antihistamines

Cetirizine Zyrtec®
Fexofenadine Allegra®
Loratadine Claritin®, various

OTC

Clemastine Tavist®
Loratadine Claritin®

Controlled Substance Drug Schedules

SCHEDULE I – Drugs that have no currently accepted medical use in treatment in TheUnited States and have a high potential for abuse. The average practitioner may notprescribe Schedule I drugs.

Examples:

Opiates, Opium derivatives such as Heroin

Hallucinogens (LSD)
Marijuana
Depressants such as: Methaqualone (Quaalude®)

SCHEDULE II – Drugs that have a high potential for abuse and have a currentlyaccepted medical use in treatment in the United States or a currently accepted medicaluse with severe restrictions.